InvestorsHub Logo
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Saturday, 03/12/2016 12:24:53 PM

Saturday, March 12, 2016 12:24:53 PM

Post# of 4493
Action on two fronts over next few months from latest Cowen presentation.

1.EVO

Partner for Japan?
5 other collaboration trials continue.
5 abstracts submitted

2.TARLOX(TH-4000)

2 Phase II trials with interim data mid-2016 (ASCO?)
4 Tarlox abstracts submitted
Tarlox is more potent than erlotinib or afatinib "in all cell lines tested"
Tarlox will be partnered before phase III IMHO.

Still trades below cash value...watch for moves as partnerships(EVO for Asia and Tarlox for world are signed)and Tarlox data hits ASCO.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTEM News